News

AstraZeneca and MedImmune are linking with the University of Michigan and Eli Lilly in a project aiming to identify new therapeutic targets for the treatment of chronic kidney disease (CKD). 

As expected, Health Secretary Jeremy Hunt has announced that a new contract will be imposed on junior doctors from August 1, after years of negations failed to reach a resolution.

It is looking likely that government will impose a new working contract for junior doctors after being advised by its lead negotiator Sir David Dalton that there is no realistic prospect of a deal.

Generic drugs giant Mylan is acquiring Swedish drugmaker Meda in a cash and stock deal valued at around $9.9 billion.

A new initiative striving to boost London’s position as a global centre for the uptake and commercialisation of pioneering digital health technologies has had its official launch in London this week.

With no signs of a resolution anytime soon, junior doctors in England have once again taken to picket lines across the country in protest against working and pay conditions being proposed by the government.

Hikma Pharmaceuticals has dropped the cash portion of its offer for Boehringer Ingelheim’s US generics unit Roxane Laboratories by some $535 million, after due diligence revealed much lower than expected revenue performance and forecasts.

Dublin, Ireland-based Alkermes has kicked off a second Phase III trail of its investigational antipsychotic ALKS 3831, testing the drug’s effect on weight against that of olanzapine (Lilly’s Zyprexa).

PharmaTimes Media invites you to join them in Atlanta on the 17 April 2016 for a celebration of excellence in clinical research.

The level of engagement in the 2016 International Clinical Researcher of the Year competition has been fantastic, with entrants hailing from 48 different countries across the globe.

The US Food and Drug Administration’s Arthritis Advisory Committee is backing the approval of Pfizer and Celltrion’s CT-P13, a biosimilar to Janssen Biotech’s blockbuster Remicade. 

Merck & Co has filed a Biologics License Application in the US for its investigational, ALK-partnered* house dust mite pill.

Public satisfaction with the National Health Service dipped five percentage points in 2015 to 60 percent, just as dissatisfaction with the service climbed eight percentage points to 23 percent, show findings from the latest British Social Attitudes (BSA) survey.

GlaxoSmithKline and US biopharma VBI Vaccines have joined forces in a research pact focused on improving vaccine stability.

Belgian drugmaker UCB and Houston, Texas-based Baylor College of Medicine have formed a strategic research alliance to discover new therapeutics for neurodegenerative diseases.